Literature DB >> 20926602

HMGA proteins regulate the expression of FGF2 in uterine fibroids.

Burkhard Maria Helmke1, Dominique Nadine Markowski, Marietta Henrike Müller, Anette Sommer, Jörg Müller, Carsten Möller, Jörn Bullerdiek.   

Abstract

In human fibroids genes encoding the high-mobility proteins containing the 'AT-hook' DNA-binding motif (HMGA) are frequently affected by non-random chromosomal rearrangements. Thus, the different proteins and their derivatives resulting from these genomic rearrangements can be assumed to be involved in the genesis of these tumors by activation of largely identical downstream pathways. Constructs encoding HMGA proteins and their relevant derivatives were overexpressed in human myometrial cells, and RNA isolated from these cells was hybridized to filter arrays. Four genes were either up- or down-regulated at least 2-fold after overexpression of either of the HMGA genes and their derivatives. FGF2 (fibroblast growth factor 2) was one of these genes, and we were then able to show by microarray analyses that tumors with rearrangements of the HMGA2 locus (n = 8) expressed significantly higher levels of FGF2 than those with an apparently normal karyotype (n = 47). Accordingly, by quantitative real-time PCR uterine leiomyomas with rearrangements of the HMGA2 locus were found to express significantly higher levels of FGF2 than those with an apparently normal karyotype with a linear relationship between the expression of FGF2 and the level of HMGA2 overexpression as well as the tumor size. The results of western blot analyses confirmed these findings. Moreover, stimulation of myometrial tissue by FGF1, a strong inducer of HMGA2, leads to an increase of HMGA2 as well as FGF2 expression. In conclusion, the results contribute to the understanding of the association between the overexpression of HMGA proteins, the regulation of FGF2 expression and the size of fibroids.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926602     DOI: 10.1093/molehr/gaq083

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  7 in total

Review 1.  Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.

Authors:  Mostafa A Borahay; Ayman Al-Hendy; Gokhan S Kilic; Darren Boehning
Journal:  Mol Med       Date:  2015-04-13       Impact factor: 6.354

2.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

Review 3.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

4.  SATB2 and NGR1: potential upstream regulatory factors in uterine leiomyomas.

Authors:  Shun Sato; Ryo Maekawa; Isao Tamura; Yuichiro Shirafuta; Masahiro Shinagawa; Hiromi Asada; Toshiaki Taketani; Hiroshi Tamura; Norihiro Sugino
Journal:  J Assist Reprod Genet       Date:  2019-11-14       Impact factor: 3.412

5.  Non-hormonal mediators of uterine fibroid growth.

Authors:  Esra Cetin; Ayman Al-Hendy; Michał Ciebiera
Journal:  Curr Opin Obstet Gynecol       Date:  2020-10       Impact factor: 1.927

6.  Abnormal spindle-like microcephaly-associated (ASPM) gene expression in posterior fossa brain tumors of childhood and adolescence.

Authors:  Débora Cabral de Carvalho Corrêa; Indhira Dias Oliveira; Bruna Mascaro Cordeiro; Frederico Adolfo Silva; Maria Teresa de Seixas Alves; Nasjla Saba-Silva; Andrea Maria Capellano; Patrícia Dastoli; Sergio Cavalheiro; Silvia Regina Caminada de Toledo
Journal:  Childs Nerv Syst       Date:  2020-06-26       Impact factor: 1.532

7.  A network pharmacology approach to investigate the pharmacological effects of Guizhi Fuling Wan on uterine fibroids.

Authors:  Liuting Zeng; Kailin Yang; Huiping Liu; Guomin Zhang
Journal:  Exp Ther Med       Date:  2017-09-21       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.